Oncology Nurse Edition

ONCOLOGY Nurse Edition®
ONCOLOGY Nurse Edition Vol 23 No 4
Volume: 23
Issue: 4
ONCOLOGY Nurse Edition Vol 23 No 2
Volume: 23
Issue: 2
ONCOLOGY Nurse Edition Vol 22 No 8
Volume: 22
Issue: 8
ONCOLOGY Nurse Edition Vol 22 No 4
Volume: 22
Issue: 4
ONCOLOGY Nurse Edition Vol 22 No 2
Volume: 22
Issue: 2
ONCOLOGY Nurse Edition Vol 25 No 10
Volume: 25
Issue: 10
ONCOLOGY Nurse Edition Vol 25 No 4
Volume: 25
Issue: 4
ONCOLOGY Nurse Edition Vol 25 No 2
Volume: 25
Issue: 2
ONCOLOGY Nurse Edition Vol 26 No 8
Volume: 26
Issue: 8
ONCOLOGY Nurse Edition Vol 26 No 5
Volume: 26
Issue: 5
ONCOLOGY Nurse Edition Vol 24 No 4
Volume: 24
Issue: 4
ONCOLOGY Nurse Edition Vol 25 No 7
Volume: 25
Issue: 7
ONCOLOGY Nurse Edition Vol 22 No 11
Volume: 22
Issue: 11
ONCOLOGY Nurse Edition Vol 24 No 2
Volume: 24
Issue: 2
ONCOLOGY Nurse Edition Vol 24 No 10
Volume: 24
Issue: 10
ONCOLOGY Nurse Edition Vol 24 No 7
Volume: 24
Issue: 7
ONCOLOGY Nurse Edition Vol 23 No 11
Volume: 23
Issue: 11
ONCOLOGY Nurse Edition Vol 23 No 8
Volume: 23
Issue: 8
Advertisement
Advertisement
Trending on CancerNetwork
1
Daraxonrasib/Vopimetostat Yield Stunning Response Rate in MTAP-del Pancreatic Cancer
2
Melanoma Trials You May Have Missed at ASCO 2026
3
80 Datopotamab Deruxtecan (Dato-DXd) + Durvalumab (D) as First-Line (1L) Treatment (tx) for Unresectable Locally Advanced/Metastatic Triple-Negative Breast Cancer (a/mTNBC): Final Results From the Phase 1b/2 BEGONIA Study
4
Subcutaneous Isatuximab Earns EU Approval in Multiple Myeloma
5
